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Abstract  
The primary malignant tumors of the small bowel are rare, representing 1 to 1.4% of all gastrointestinal tumors. We report a case of a 33 year-old 
women, admitted to our emergency department of visceral surgery for acute abdomen. The clinical examination revealed diffuse abdominal 
distension, defenseless, the hernia orifices were free and the rectal examination was normal. The biological test showed no hydro electrolytic 
disorders with normal hemoglobin and normal renal function. The abdominal CT-Scan showed signs of bowel obstruction due to a volvulus with 
intussusception without ischemia. The patient was operated urgently; the exploration has revealed a small bowel obstruction in the ileum with 
volvulus, an intussusceptum associated with a retractile mesenteritis, and the hepatic exploration found no metastases. The patient underwent a 
bowel resection taking away the intussusceptum with the infiltrated mesentery. The postoperative course was uneventful. The pathological result 
has proved a well-differentiated neuroendocrine tumor with five free nodes. Through this observation, we aim to highlight that an obstruction of 
small bowel with volvulus and intussusception could be exceptionally due to a neuroendocrine tumor, this complication has enabled a relatively 
early diagnosis in the absence of metastases and a 6-month follow-up without recurrence is a demonstration. 
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Primary malignant tumors of the small bowel are rare, representing 
1 to 1.4% of all gastrointestinal tumors [1]. The malignant tumors 
of the small bowel symptoms are not specific; consequently, 
diagnosis is difficult and delayed. Unlike children, 90% of 
intussusception in adults are due to a well-established pathology as 
carcinoma, polyp, Meckel's diverticulum, and benign tumors [2]. 
Surgical emergency is often secondary to bowel obstruction, 
perforation and hemorrhage [3]. Through this observation, we aim 
to highlight that an obstruction of small bowel with volvulus and 
intussusception could be exceptionally due to a neuroendocrine 
tumor, this complication has enabled a relatively early diagnosis in 
the absence of metastases and a 6-month follow up without 
recurrence is a demonstration.  
  
  
Patient and observation 
 
A 33 year-old women, of Nigerian origin, was admitted to our 
emergency department of visceral surgery, with an acute abdomen 
with a previous history of 3 days of vomiting, pain and abdominal 
distention without a family history of gastrointestinal tumors. The 
physical examination revealed a defenseless, diffuse abdominal 
distension, the hernial orifices were free and the rectal examination 
was normal. The abdomen without preparation showed air-fluid 
levels of small bowel type. The biological test showed a WBC at 
15200/ml, CRP at 188 mg /L, hemoglobin at 12, 1 g/dl without 
hydro electrolytic troubles. The abdominal CT-Scan showed bowel 
obstruction signs due to a volvulus intussusception without ischemia 
(Figure 1).  
  
The patient was operated urgently, the exploration revealed a small 
bowel obstruction in the ileum with volvulus, an intussusceptum 
(Figure 2) associated to a retractile mesenteritis without ischemia 
(Figure 3). The liver palpation found no metastasis. The 
exploration of the rest of the abdomen was normal. The patient 
underwent a bowel resection taking away the intussusceptum with 
the infiltrated mesentery. The postoperative course was uneventful. 
Given the absence of clinical carcinoid syndrome and the absence of 
metastases, no additional treatment was proposed to the patient. 
The pathological result has proved a neuroendocrine tumor with 
free five nodes. The tumor was largely necrotic (Figure 4). A panel 
of antibodies was performed for the immunohistochemical study, 
the tumor cells expressed antichromogranine (Figure 5) but they 
are negative for antisynaptophysine, anti CD 56, and Ki 67. After 6 
months of the intervention, the patient was seen in consultation 





Neuroendocrine tumors are more common in women than in men 
with a maximum difference between the two genders for the age 
group between 15 and 19 years (sex ratio = 2.14) and constitute 
55% of all endocrine tumors and 12 to 35% of all the small bowel 
tumors; a family risk for this disease is also reported [4,5]. Within 
the gastrointestinal tract, most carcinoid tumors occurred in the 
small intestine (41,8%), rectum (27,4%), and stomach (8,7%) [6]. 
Most neuroendocrine tumors are clinically asymptomatic, for this 
reason they are frequently found incidentally during surgery for 
potential complications, in endoscopy or in imaging performed for 
other pathology. The classic triad of carcinoid syndrome makes 
facial flushing, diarrhea and bronchospasm, sign a metastatic 
disease almost always hepatic or in case of primary tumor on the 
systemic circulation (bronchi) and reveals the diagnosis in 2-5% of 
cases [7-9]. When the neuroendocrine tumor infiltrates the entire 
wall of the small bowel it creates a desmoplastic reaction followed 
by obstruction and stenosis [10]. Recently neuroendocrine tumors 
are diagnosed increasingly and precociously improving the 
prognosis. The reason for this striking increase of diagnosis is often 
correlate with the increased use of high-resolution imaging, 
endoscopy and the improvement of immunohistochemical 
techniques [11]. In the United States, according to the SEER 
registry (surveillance, epidemiology and end result), the 5-year 
survival rate in patients with neuroendocrine tumors of the small 
bowel has grown up to 51.9% between 1970 s and 1980s and to 
60, 5% in 1990´s [6]. STROSBERG et al observed a 5- year survival 
rate of 75% [12].  
  
Although the mitotic index, female gender, the presence of a 
carcinoid syndrome is recognized as predictive factors of poor 
prognosis, tumor size, muscolaris propria invasion, lymph node 
infiltration or metastases are the safest features to predict the 
outcomes [13]. Surgery remains a treatment of choice for early 
neuroendocrine tumors of the jejunum and ileum, peritoneal 
carcinomatosis or systemic extension characterizes the palliative 
situation and requires a multidisciplinary approach, especially in the 
presence of a well-differentiated tumor of the ileum. The treatment 
of non-metastatic forms based on a complete surgical excision to 
obtain a resection passing macroscopically to normal area (R0) the 
only way to improve patient survival at 5 years [6,7,9]. Medical 
treatment appears to be particularly effective if treatment of hepatic 
metastases is performed [12]. When a carcinoid syndrome appears, 
the somatostatin analogs are the treatment of choice to control the 
symptoms. These are initially effective in 60-90% of patients, but 
can gradually become ineffective. However, treatment with 
somatostatin analogues is symptomatic treatment and rarely gives a 
decrease in tumor size [14]. The described case seems to be the 
third reported case in which the diagnosis was made due to the 
onset of a volvulus, with only two other similar cases reported in the 
literature [15,16]. This complication has allowed a relatively early 
diagnosis in the absence of metastases and a 6-month follow-up 





In recent years, major improvements have been made in the 
diagnosis and in the multidisciplinary approach in the treatment of 
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Figures 
 
Figure 1: Abdominal CT- Scan, frontal slice, showing the 
intussusception and the volvulus of the small bowel  
Figure 2: Intussusception and the volvulus of the small bowel  
Figure 3: distal ileum after detorsion showing the retractable 
mesenteritis  
Figure 4: Neuroendocrine tumor of the small bowel showing 
necrotic wall with hemalun eosin (magnification×100)  
Figure 5: Intense immunohistochimical expression of 
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Figure 1: Abdominal CT- Scan, frontal slice, 
showing the intussusception and the volvulus 











Figure 3: distal ileum after detorsion showing the 
retractable mesenteritis  
 




Figure 4: Neuroendocrine tumor of the small bowel showing 





Figure 5: Intense immunohistochimical expression of 
chromogranine A in small bowel neuroendocrine tumor 
(magnification×400) 
 
 
 
 
 
 
